The Role of the Vagus Nerve in Tumor-to-Brain Communication in Lung Cancer Patients
NCT00397124 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2006-11-08
Summary
the aim of this study is to measure brain metabolism in patients with lung cancer.FDG uptake in the brain in patients with malignant tumors will be compared to the amount of tracer activity found in patients who have benign pulmonary process. if differences between the brain uptake of FDG in the two groups will be found, further assessment will be performed in order to evaluate if such differences could be attributed and specifically localized to the brain regions innervated by the vagus
Conditions
Interventions
- DEVICE
-
PET/CT imaging
Sponsors & Collaborators
-
Rambam Health Care Campus
lead OTHER
Principal Investigators
-
Ora Israel, MD · Rambam Health Care Campus
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 35 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-04-30
Countries
- Israel
Study Locations
More Related Trials
-
PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer
NCT03146117 ·Status: TERMINATED
-
The Utility of FDG-PET for Radiation Treatment in NSCLC
NCT00385164 ·Status: UNKNOWN
-
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients
NCT04678440 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients
NCT02016872 ·Status: COMPLETED ·Phase: NA
-
PET/CT to Identify "Vulnerable" Arterial Plaque
NCT00416065 ·Status: UNKNOWN ·Phase: NA
-
PET Scan and CT Scan in Evaluating Response in Patients Undergoing Radiofrequency Ablation for Lung Metastases
NCT00382252 ·Status: COMPLETED ·Phase: NA
-
FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy
NCT00424138 ·Status: TERMINATED ·Phase: NA
-
PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)
NCT00201942 ·Status: COMPLETED ·Phase: PHASE3
-
Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET
NCT00180154 ·Status: COMPLETED
-
The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients
NCT06082492 ·Status: RECRUITING ·Phase: NA
-
PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404
NCT01540513 ·Status: COMPLETED ·Phase: NA
-
PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer
NCT04151940 ·Status: RECRUITING ·Phase: NA
-
18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors
NCT02167204 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
NCT00004138 ·Status: COMPLETED ·Phase: NA
-
Use of [18]F-FDG on PET/CT as an Alternative Non-invasive Method for Staging of Lung Cancer
NCT02664792 ·Status: COMPLETED ·Phase: NA
-
The Role of 18F-FDG-PET/CT Scan in Lung Cancer Patients
NCT04395651 ·Status: UNKNOWN
-
99mTc-3PRGD2 SPECT/CT in Lung Cancer Patients
NCT01737112 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer
NCT05452005 ·Status: RECRUITING ·Phase: PHASE1
-
Predictive Value of PET CT in the Histologic Lymph Node Status of Patients With Squamous Cell Carcinoma of the Oral N0 Clinical and Radiological Cavity.
NCT03947892 ·Status: UNKNOWN
-
PET/CT Imaging of Malignant Brain Tumors With 124I-NM404
NCT01516905 ·Status: COMPLETED
-
Role of FDG PET, Immune and Hypoxic Marker in NSCLC
NCT02519062 ·Status: COMPLETED
-
PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma
NCT00346125 ·Status: COMPLETED ·Phase: NA
-
18F-Fluciclovine PET to Distinguish Tumor Progression From Radiation Necrosis
NCT03930173 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer
NCT00123747 ·Status: COMPLETED ·Phase: PHASE2
-
PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery
NCT00002930 ·Status: COMPLETED ·Phase: PHASE2/PHASE3